Abstract
4010Background: NAPA is an oral investigational agent, hypothesized to inhibit cancer stemness pathways, including STAT3 pathway implicated in cancer stem-cell viability. Synergistic antitumor acti...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have